Nguyen-Dien, Giang Thanh https://orcid.org/0000-0002-3136-0485
Townsend, Brendan https://orcid.org/0000-0003-2839-8981
Kulkarni, Prajakta Gosavi https://orcid.org/0000-0002-0960-8237
Kozul, Keri-Lyn https://orcid.org/0000-0001-5162-4807
Ooi, Soo Siang
Eldershaw, Denaye N https://orcid.org/0009-0000-8032-0378
Weeratunga, Saroja https://orcid.org/0009-0009-8417-7420
Liu, Meihan https://orcid.org/0009-0006-7463-4497
Jones, Mathew JK https://orcid.org/0000-0003-2714-8411
Millard, S Sean https://orcid.org/0000-0001-8573-4625
Ng, Dominic CH
Pagano, Michele https://orcid.org/0000-0003-3210-2442
Bonfim-Melo, Alexis
Schneider, Tobias https://orcid.org/0009-0009-6076-9202
Komander, David https://orcid.org/0000-0002-8092-4320
Lazarou, Michael https://orcid.org/0000-0003-2150-5545
Collins, Brett M https://orcid.org/0000-0002-6070-3774
Pagan, Julia K https://orcid.org/0000-0002-7079-6388
Funding for this research was provided by:
DHAC | National Health and Medical Research Council (APP1183915 and APP1136021)
DHAC | National Health and Medical Research Council (APP2016410)
Department of Education and Training | Australian Research Council (FT180100172)
Mito Foundation
Brain Foundation
Article History
Received: 21 April 2024
Revised: 30 May 2024
Accepted: 4 June 2024
First Online: 11 July 2024
Disclosure and competing interests statement
: DK is founder, shareholder and member of the SAB of Entact Bio and Proxima Bio. MP is a scientific cofounder of SEED Therapeutics; received research funding from and is a shareholder in Kymera Therapeutics; and is a consultant for, a member of the scientific advisory board of, and has financial interests in CullGen, SEED Therapeutics, Triana Biomedicines, and Umbra Therapeutics. However, no research funds were received from these entities, and the findings presented in this manuscript were not discussed with any person in these companies. ML is a member of the scientific advisory board and co-founder of Automera. The remaining authors declare no competing interests.